Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 25242048

Abiraterone acetate for patients with metastatic castration-resistant prostate cancer progressing after chemotherapy: final analysis of a multicentre, open-label, early-access protocol trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2014 Oct
First author
Sternberg CN

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2014 Nov;15(12):e528
    note
    Source null
    related pmid
    Source null
    relationship
    Erratum in
    url
    Source null
  2. citation
    Lancet Oncol. 2014 Oct;15(11):1188-90. doi: 10.1016/S1470-2045(14)70463-2.
    note
    Source null
    related pmid
    25242047
    relationship
    Comment in

Authors and identifiers

  1. name
    Sternberg CN
    type
    Author
  2. name
    Castellano D
    type
    Author
  3. name
    Daugaard G
    type
    Author
  4. name
    Géczi L
    type
    Author
  5. name
    Hotte SJ
    type
    Author
  6. name
    Mainwaring PN
    type
    Author
  7. name
    Saad F
    type
    Author
  8. name
    Souza C
    type
    Author
  9. name
    Tay MH
    type
    Author
  10. name
    Garrido JM
    type
    Author
  11. name
    Galli L
    type
    Author
  12. name
    Londhe A
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Sternberg CN
    type
    Author
  2. name
    Castellano D
    type
    Author
  3. name
    Daugaard G
    type
    Author
  4. name
    Géczi L
    type
    Author
  5. name
    Hotte SJ
    type
    Author
  6. name
    Mainwaring PN
    type
    Author
  7. name
    Saad F
    type
    Author
  8. name
    Souza C
    type
    Author
  9. name
    Tay MH
    type
    Author
  10. name
    Garrido JM
    type
    Author
  11. name
    Galli L
    type
    Author
  12. name
    Londhe A
    type
    Author
bibliography ids
  1. nci-bib-c949f37d12964ba151852a2d
book metadata
content sha256
1f01fc1baa65c765ab17b136581939b0f1b21ae914d41dbd9ece23c0458c449d
document type
citation
dois
  1. 10.1016/S1470-2045(14)70417-6
electronic publication date
display
2014 Sep 18
precision
day
year
2014
evidence scope
bibliographic_metadata_only
id
pubmed:25242048
immutable id
pubmed:25242048@1f01fc1baa65c765ab17b136581939b0f1b21ae914d41dbd9ece23c0458c449d
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
11
name
The Lancet. Oncology
nlm unique id
100957246
pages
1263-8
volume
15
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2014 Nov;15(12):e528
    note
    Source null
    related pmid
    Source null
    relationship
    Erratum in
    url
    Source null
  2. citation
    Lancet Oncol. 2014 Oct;15(11):1188-90. doi: 10.1016/S1470-2045(14)70463-2.
    note
    Source null
    related pmid
    25242047
    relationship
    Comment in
outcomes validated
false
pmid
25242048
provenance
batch id
69903be8ceab8801c81a
provider
NCBI PubMed ESummary
record sha256
1ad89efba0c4665f758e58fd07f38c9e3f7552a72c469636e2ee621f17aad1a2
response sha256
1e367491c3c459a93f45b3db99ca1f9293ed2287c48bdf758bb088ffcd7c96eb
retrieved at
2026-09-09T23:47:05.208886+00:00
publication date
display
2014 Oct
precision
month
year
2014
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/25242048/
title
Abiraterone acetate for patients with metastatic castration-resistant prostate cancer progressing after chemotherapy: final analysis of a multicentre, open-label, early-access protocol trial.

Preserved source evidence · Not medical advice